Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total assets
Total assets on the balance sheet as of March 2023 : $94.28 B
According to Bristol-Myers Squibb's latest financial reports the company's total assets are $94.28 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bristol-Myers Squibb - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $96.82 B | -11.43% |
| 2021-12-31 | $109.31 B | -7.74% |
| 2020-12-31 | $118.48 B | -8.82% |
| 2019-12-31 | $129.94 B | 271.42% |
| 2018-12-31 | $34.98 B | 4.28% |
| 2017-12-31 | $33.55 B | -0.46% |
| 2016-12-31 | $33.70 B | 6.17% |
| 2015-12-31 | $31.74 B | -5.93% |
| 2014-12-31 | $33.74 B | -12.55% |
| 2013-12-31 | $38.59 B | 7.51% |
| 2012-12-31 | $35.89 B | 8.88% |
| 2011-12-31 | $32.97 B | 6.09% |
| 2010-12-31 | $31.07 B | 0.22% |
| 2009-12-31 | $31.00 B | 4.93% |
| 2008-12-31 | $29.55 B | 12.91% |
| 2007-12-31 | $26.17 B | 2.33% |
| 2006-12-31 | $25.57 B | -9.11% |
| 2005-12-31 | $28.13 B | -7.55% |
| 2004-12-31 | $30.43 B | 10.79% |
| 2003-12-31 | $27.47 B | 10.44% |
| 2002-12-31 | $24.87 B | -8.07% |
| 2001-12-31 | $27.05 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 98.74% | 🇺🇸 USA |
 Novartis NVS | $112.24 B | 19.05% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 109.17% | 🇺🇸 USA |
 AbbVie ABBV | $138.80 B | 47.22% | 🇺🇸 USA |
 Eli Lilly LLY | $53.16 B | -43.61% | 🇺🇸 USA |
 Amgen AMGN | $88.72 B | -5.90% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | 43.95% | 🇫🇷 France |
 Biogen BIIB | $24.59 B | -73.91% | 🇺🇸 USA |
 Merck MRK | $109.16 B | 15.78% | 🇺🇸 USA |
 AstraZeneca AZN | $96.68 B | 2.55% | 🇬🇧 UK |